FFTY:NYE-Innovator IBD® 50 ETF (USD)

ETF | Mid-Cap Growth |

Last Closing

USD 26.97

Change

+0.56 (+2.12)%

Market Cap

N/A

Volume

0.04M

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-19 )

Largest Industry Peers for Mid-Cap Growth

Symbol Name Price(Change) Market Cap
IWP iShares Russell Mid-Cap Growth..

+1.93 (+1.68%)

USD 14.02B
VOT Vanguard Mid-Cap Growth Index ..

+4.14 (+1.75%)

USD 13.54B
IJK iShares S&P Mid-Cap 400 Growth..

+1.57 (+1.73%)

USD 9.62B
XMMO Invesco S&P MidCap Momentum ET..

+2.70 (+2.29%)

USD 2.35B
IVOG Vanguard S&P Mid-Cap 400 Growt..

+1.74 (+1.54%)

USD 1.02B
ETHO Amplify ETF Trust

+1.06 (+1.79%)

USD 0.18B
CWS AdvisorShares Focused Equity E..

+0.71 (+1.05%)

USD 0.17B
IPO Renaissance IPO ETF

+0.37 (+0.86%)

USD 0.15B
BFOR Barron's 400 ETF

+1.24 (+1.76%)

USD 0.14B
PEXL Pacer US Export Leaders ETF

+1.09 (+2.23%)

USD 0.07B

ETFs Containing FFTY

N/A

Market Performance

  Market Performance vs. Industry/Classification (Mid-Cap Growth) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 10.67% 40% F 59% D-
Dividend Return N/A N/A N/A N/A N/A
Total Return 10.67% 40% F 50% F
Trailing 12 Months  
Capital Gain 22.76% 38% F 66% D+
Dividend Return 0.72% 53% F 8% B-
Total Return 23.47% 38% F 61% D-
Trailing 5 Years  
Capital Gain -18.42% 6% D- 24% F
Dividend Return 2.59% 29% F 8% B-
Total Return -15.83% 6% D- 17% F
Average Annual (5 Year Horizon)  
Capital Gain -1.92% 6% D- 27% F
Dividend Return -1.26% 6% D- 18% F
Total Return 0.66% 60% D- 15% F
Risk Return Profile  
Volatility (Standard Deviation) 29.52% 19% F 35% F
Risk Adjusted Return -4.28% 6% D- 23% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Poor risk adjusted returns

This company is delivering below median risk adjusted returns in its peers. Even if it is outperforming on returns , the returns are unpredictable. Proceed with caution.

Below median dividend returns

The company’s average income yield over the past 5 years has been low compared to its peers. However, it is not a problem if you are not looking for income.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.